A Study Assessing the REG1 Anticoagulation System Compared Heparin in Subjects With Acute Coronary Syndrome

NCT00932100 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

640

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Coronary Syndrome (ACS)

Interventions

DRUG: REG1
DRUG: Heparin

Sponsor

Regado Biosciences, Inc.